Thus, we sought to evaluate the longitudinal effects of chronic metformin treatment on brain glucose metabolism, as well as to study its effect after long-term treatment on key players of the insulin signalling pathway, which are known to be altered both in patients with AD and in two lines of animal models with preclinical AD [35,36]. Here, INS is linked to Alzheimer disease.